Cargando…
Hypoxia inducible factor 1α gene (HIF-1α) splice variants: potential prognostic biomarkers in breast cancer
BACKGROUND: Hypoxia-inducible factor 1 (HIF-1) is a master transcriptional regulator of genes regulating oxygen homeostasis. The HIF-1 protein is composed of two HIF-1α and HIF-1β/aryl hydrocarbon receptor nuclear translocator (ARNT) subunits. The prognostic relevance of HIF-1α protein overexpressio...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917392/ https://www.ncbi.nlm.nih.gov/pubmed/20624301 http://dx.doi.org/10.1186/1741-7015-8-44 |
_version_ | 1782185063246462976 |
---|---|
author | Dales, Jean-Philippe Beaufils, Nathalie Silvy, Monique Picard, Christophe Pauly, Vanessa Pradel, Vincent Formisano-Tréziny, Christine Bonnier, Pascal Giusiano, Sophie Charpin, Colette Gabert, Jean |
author_facet | Dales, Jean-Philippe Beaufils, Nathalie Silvy, Monique Picard, Christophe Pauly, Vanessa Pradel, Vincent Formisano-Tréziny, Christine Bonnier, Pascal Giusiano, Sophie Charpin, Colette Gabert, Jean |
author_sort | Dales, Jean-Philippe |
collection | PubMed |
description | BACKGROUND: Hypoxia-inducible factor 1 (HIF-1) is a master transcriptional regulator of genes regulating oxygen homeostasis. The HIF-1 protein is composed of two HIF-1α and HIF-1β/aryl hydrocarbon receptor nuclear translocator (ARNT) subunits. The prognostic relevance of HIF-1α protein overexpression has been shown in breast cancer. The impact of HIF-1α alternative splice variant expression on breast cancer prognosis in terms of metastasis risk is not well known. METHODS: Using real-time quantitative reverse transcription PCR assays, we measured mRNA concentrations of total HIF-1α and 4 variants in breast tissue specimens in a series of 29 normal tissues or benign lesions (normal/benign) and 53 primary carcinomas. In breast cancers HIF-1α splice variant levels were compared to clinicopathological parameters including tumour microvessel density and metastasis-free survival. RESULTS: HIF-1α isoforms containing a three base pairs TAG insertion between exon 1 and exon 2 (designated HIF-1α(TAG)) and HIF-1α(736 )mRNAs were found expressed at higher levels in oestrogen receptor (OR)-negative carcinomas compared to normal/benign tissues (P = 0.009 and P = 0.004 respectively). In breast carcinoma specimens, lymph node status was significantly associated with HIF-1α(TAG )mRNA levels (P = 0.037). Significant statistical association was found between tumour grade and HIF-1α(TAG )(P = 0.048), and total HIF-1α (P = 0.048) mRNA levels. HIF-1α(TAG )mRNA levels were also inversely correlated with both oestrogen and progesterone receptor status (P = 0.005 and P = 0.033 respectively). Univariate analysis showed that high HIF-1α(TAG )mRNA levels correlated with shortened metastasis free survival (P = 0.01). CONCLUSIONS: Our results show for the first time that mRNA expression of a HIF-1α(TAG )splice variant reflects a stage of breast cancer progression and is associated with a worse prognosis. See commentary: http://www.biomedcentral.com/1741-7015/8/45 |
format | Text |
id | pubmed-2917392 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-29173922010-08-07 Hypoxia inducible factor 1α gene (HIF-1α) splice variants: potential prognostic biomarkers in breast cancer Dales, Jean-Philippe Beaufils, Nathalie Silvy, Monique Picard, Christophe Pauly, Vanessa Pradel, Vincent Formisano-Tréziny, Christine Bonnier, Pascal Giusiano, Sophie Charpin, Colette Gabert, Jean BMC Med Research Article BACKGROUND: Hypoxia-inducible factor 1 (HIF-1) is a master transcriptional regulator of genes regulating oxygen homeostasis. The HIF-1 protein is composed of two HIF-1α and HIF-1β/aryl hydrocarbon receptor nuclear translocator (ARNT) subunits. The prognostic relevance of HIF-1α protein overexpression has been shown in breast cancer. The impact of HIF-1α alternative splice variant expression on breast cancer prognosis in terms of metastasis risk is not well known. METHODS: Using real-time quantitative reverse transcription PCR assays, we measured mRNA concentrations of total HIF-1α and 4 variants in breast tissue specimens in a series of 29 normal tissues or benign lesions (normal/benign) and 53 primary carcinomas. In breast cancers HIF-1α splice variant levels were compared to clinicopathological parameters including tumour microvessel density and metastasis-free survival. RESULTS: HIF-1α isoforms containing a three base pairs TAG insertion between exon 1 and exon 2 (designated HIF-1α(TAG)) and HIF-1α(736 )mRNAs were found expressed at higher levels in oestrogen receptor (OR)-negative carcinomas compared to normal/benign tissues (P = 0.009 and P = 0.004 respectively). In breast carcinoma specimens, lymph node status was significantly associated with HIF-1α(TAG )mRNA levels (P = 0.037). Significant statistical association was found between tumour grade and HIF-1α(TAG )(P = 0.048), and total HIF-1α (P = 0.048) mRNA levels. HIF-1α(TAG )mRNA levels were also inversely correlated with both oestrogen and progesterone receptor status (P = 0.005 and P = 0.033 respectively). Univariate analysis showed that high HIF-1α(TAG )mRNA levels correlated with shortened metastasis free survival (P = 0.01). CONCLUSIONS: Our results show for the first time that mRNA expression of a HIF-1α(TAG )splice variant reflects a stage of breast cancer progression and is associated with a worse prognosis. See commentary: http://www.biomedcentral.com/1741-7015/8/45 BioMed Central 2010-07-12 /pmc/articles/PMC2917392/ /pubmed/20624301 http://dx.doi.org/10.1186/1741-7015-8-44 Text en Copyright ©2010 Dales et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Dales, Jean-Philippe Beaufils, Nathalie Silvy, Monique Picard, Christophe Pauly, Vanessa Pradel, Vincent Formisano-Tréziny, Christine Bonnier, Pascal Giusiano, Sophie Charpin, Colette Gabert, Jean Hypoxia inducible factor 1α gene (HIF-1α) splice variants: potential prognostic biomarkers in breast cancer |
title | Hypoxia inducible factor 1α gene (HIF-1α) splice variants: potential prognostic biomarkers in breast cancer |
title_full | Hypoxia inducible factor 1α gene (HIF-1α) splice variants: potential prognostic biomarkers in breast cancer |
title_fullStr | Hypoxia inducible factor 1α gene (HIF-1α) splice variants: potential prognostic biomarkers in breast cancer |
title_full_unstemmed | Hypoxia inducible factor 1α gene (HIF-1α) splice variants: potential prognostic biomarkers in breast cancer |
title_short | Hypoxia inducible factor 1α gene (HIF-1α) splice variants: potential prognostic biomarkers in breast cancer |
title_sort | hypoxia inducible factor 1α gene (hif-1α) splice variants: potential prognostic biomarkers in breast cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917392/ https://www.ncbi.nlm.nih.gov/pubmed/20624301 http://dx.doi.org/10.1186/1741-7015-8-44 |
work_keys_str_mv | AT dalesjeanphilippe hypoxiainduciblefactor1agenehif1asplicevariantspotentialprognosticbiomarkersinbreastcancer AT beaufilsnathalie hypoxiainduciblefactor1agenehif1asplicevariantspotentialprognosticbiomarkersinbreastcancer AT silvymonique hypoxiainduciblefactor1agenehif1asplicevariantspotentialprognosticbiomarkersinbreastcancer AT picardchristophe hypoxiainduciblefactor1agenehif1asplicevariantspotentialprognosticbiomarkersinbreastcancer AT paulyvanessa hypoxiainduciblefactor1agenehif1asplicevariantspotentialprognosticbiomarkersinbreastcancer AT pradelvincent hypoxiainduciblefactor1agenehif1asplicevariantspotentialprognosticbiomarkersinbreastcancer AT formisanotrezinychristine hypoxiainduciblefactor1agenehif1asplicevariantspotentialprognosticbiomarkersinbreastcancer AT bonnierpascal hypoxiainduciblefactor1agenehif1asplicevariantspotentialprognosticbiomarkersinbreastcancer AT giusianosophie hypoxiainduciblefactor1agenehif1asplicevariantspotentialprognosticbiomarkersinbreastcancer AT charpincolette hypoxiainduciblefactor1agenehif1asplicevariantspotentialprognosticbiomarkersinbreastcancer AT gabertjean hypoxiainduciblefactor1agenehif1asplicevariantspotentialprognosticbiomarkersinbreastcancer |